PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
9.81%
Net income growth under 50% of MRVL's 172.18%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-15.81%
Negative yoy D&A while MRVL is 0.26%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-133.33%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
No Data
No Data available this quarter, please select a different quarter.
-129.19%
Both reduce yoy usage, with MRVL at -213.03%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
22.58%
AR growth while MRVL is negative at -589.51%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-261.54%
Negative yoy inventory while MRVL is 101.60%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-254.29%
Both negative yoy AP, with MRVL at -4.41%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-49.25%
Both reduce yoy usage, with MRVL at -124.33%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
40.00%
Lower 'other non-cash' growth vs. MRVL's 127.86%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
-2.92%
Both yoy CFO lines are negative, with MRVL at -38.53%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-163.79%
Negative yoy CapEx while MRVL is 38.53%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-86.01%
Negative yoy acquisition while MRVL stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-118.37%
Negative yoy purchasing while MRVL stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
105.93%
Liquidation growth of 105.93% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
94.86%
Growth well above MRVL's 24.16%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-152.15%
We reduce yoy invests while MRVL stands at 38.35%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
63.21%
We repay more while MRVL is negative at -50.00%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
-30.67%
Negative yoy issuance while MRVL is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-2.16%
We cut yoy buybacks while MRVL is 1.71%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.